1. Serum and alveolar procalcitonin had a weak diagnostic value for ventilator-associated pneumonia in patients with pulmonary infection score ≥ 6
   Mehran Shokri et al, 2018, Romanian Journal of Internal Medicine CrossRef
2. Respuesta inmune e inmunosupresión en pacientes con ventilación mecánica por infección por SARS-CoV-2
   Celia Margarita Coronado Robles et al, 2022, Medicina Crítica CrossRef
3. Gut Microbiota as Early Predictor of Infectious Complications before Cardiac Surgery: A Prospective Pilot Study
   Ekaterina Chernevskaya et al, 2021, Journal of Personalized Medicine CrossRef
4. Role of procalcitonin as a biomarker in early identification of adverse events following esophageal atresia surgery
   Prabudh Goel et al, 2023, Journal of Indian Association of Pediatric Surgeons CrossRef
5. Relevance of Endothelial Cell-Specific Molecule 1 (Endocan) Plasma Levels for Predicting Pulmonary Infection after Cardiac Surgery in Chronic Kidney Disease Patients: The Endolung Pilot Study
   Andréa Perrotti et al, 2018, Cardiorenal Medicine CrossRef
6. Procalcitonin in special patient populations: Guidance for antimicrobial therapy
   Susan E Smith et al, 2020, American Journal of Health-System Pharmacy CrossRef
7. Procalcitonin for the diagnosis of postoperative bacterial infection after adult cardiac surgery: a systematic review and meta-analysis
   Davide Nicolotti et al, 2024, Critical Care CrossRef
8. Postoperative Serum Procalcitonin Level Can Be a Useful Marker of Bacterial Infection after Cardiac Surgery Utilizing Cardiopulmonary Bypass
   Niramol Tongboon et al, 2024, Journal of Cardiac Surgery CrossRef
9. Kinetics of endocan in patients undergoing cardiac surgery with and without cardiopulmonary bypass
   Pierre-Alain Poinsot et al, 2018, Cytokine CrossRef
10. Procalcitonin as a biomarker to guide treatments for patients with lower respiratory tract infections
    Ouriel Saura et al, 2023, Expert Review of Respiratory Medicine CrossRef
11. The diagnostic accuracy of procalcitonin in infectious patients after cardiac surgery: a systematic review and meta-analysis
    Qianqin Li et al, 2021, Journal of Cardiovascular Medicine CrossRef
12. Is Endocan a Diagnostic Marker for Pneumonia After Cardiac Surgery? The ENDOLUNG Study
    Andréa Perrotti et al, 2018, The Annals of Thoracic Surgery CrossRef
13. A systematic review and consensus definitions for standardised end-points in perioperative medicine: pulmonary complications
    T.E.F. Abbott et al, 2018, British Journal of Anaesthesia CrossRef
14. Endocan, sepsis, pneumonia, and acute respiratory distress syndrome
    Nathalie De Freitas Caires et al, 2018, Critical Care CrossRef
15. The current status of biomarkers for the diagnosis of nosocomial pneumonias
    Jorge I.F. Salluh et al, 2017, Current Opinion in Critical Care CrossRef
16. Laryngoscope‑assisted and cotton ball wiping methods in prevention of oral and pulmonary infection in patients receiving mechanical ventilation and the influence on hypersensitive C‑reactive protein and procalcitonin
    Pingji Zhang et al, 2019, Experimental and Therapeutic Medicine CrossRef
17. Systematic review of studies investigating ventilator associated pneumonia diagnostics in intensive care
    Basem Al-Omari et al, 2021, BMC Pulmonary Medicine CrossRef
18. Values of serum LDL and PCT levels in evaluating the condition and prognosis of acute cerebral infarction
    Xianliang Meng et al, 2018, Experimental and Therapeutic Medicine CrossRef
19. The predictive value of procalcitonin in ventilator-associated pneumonia after cardiac valve replacement
    Yan-Yan Song et al, 2020, Scandinavian Journal of Clinical and Laboratory Investigation CrossRef
20. A comparison of diagnostic algorithms and clinical parameters to diagnose ventilator-associated pneumonia: a prospective observational study
    Farshid Rahimibashar et al, 2021, BMC Pulmonary Medicine CrossRef